RACHEL ENSLEY: Open Payments
NPI 1164905865 · MOSCOW, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 13 payments from 11 companies in 2025. Trend: 2023 $211 · 2024 $40 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| ABBVIE INC. | 1 | $26 |
| Celgene Corporation | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| EMD Serono, Inc. | 1 | $19 |
| Aveo Pharmaceuticals, Inc. | 1 | $14 |
Products named: PTEYE PARATHYROID DETECTION SYSTEM, OPDUALAG, KEYTRUDA, LUTATHERA, EPKINLY, REBLOZYL, SARCLISA, VERZENIO.
Industry payments across ID — which companies pay providers there.
